The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults (D1AMOND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05615220
Recruitment Status : Recruiting
First Posted : November 14, 2022
Last Update Posted : June 14, 2024
Information provided by (Responsible Party):
Emalex Biosciences Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2024
Estimated Study Completion Date : December 2024